Quasi-LD-Targeted and ONOO--Responsive Fluorescent Probe for Investigating the Interaction of Nonalcoholic Fatty Liver with Drug-Induced Liver Injury.
暂无分享,去创建一个
Weili Zhao | Jian Zhang | Jiamin Wang | Nannan Wang | Han Wang | Xiaoyan Lu | Bo Zhang
[1] Jian Zhang,et al. BODIPY-based fluorescent probe for cysteine detection and its applications in food analysis, test strips and biological imaging. , 2023, Food chemistry.
[2] Yijia Liu,et al. Dual-Channel Fluorescent Probe for Detecting Viscosity and ONOO- without Signal Crosstalk in Nonalcoholic Fatty Liver. , 2022, Analytical chemistry.
[3] Dai-Wen Pang,et al. BOIMPY-Based NIR-II Fluorophore with High Brightness and Long Absorption beyond 1000 nm for In Vivo Bioimaging: Synergistic Steric Regulation Strategy. , 2022, ACS nano.
[4] Yang Shen,et al. Advances in Optical Imaging of Nonalcoholic Fatty Liver Disease. , 2022, Chemistry, an Asian journal.
[5] Soo-Jin Lee,et al. Highly Sensitive Two-Photon Lipid Droplet Tracker for In Vivo Screening of Drug Induced Liver Injury. , 2022, ACS sensors.
[6] He He,et al. Loss of Sam50 in hepatocytes induces cardiolipin‐dependent mitochondrial membrane remodeling to trigger mtDNA release and liver injury , 2022, Hepatology.
[7] Guomin Xia,et al. H‐Dimeric Nanospheres of Amphipathic Squaraine Dye with an 81.2% Photothermal Conversion Efficiency for Photothermal Therapy , 2022, Advanced Functional Materials.
[8] Fawei Zhu,et al. Evaluation of Nitric Oxide Fluctuation Via a Fast, Responsive Fluorescent Probe in Idiopathic Pulmonary Fibrosis Cells and Mice Models. , 2022, Analytical chemistry.
[9] Zhuoyue Song,et al. Exploiting the Twisted Intramolecular Charge Transfer Effect to Construct a Wash-Free Solvatochromic Fluorescent Lipid Droplet Probe for Fatty Liver Disease Diagnosis. , 2022, Analytical chemistry.
[10] Yong Ye,et al. Recent advances in multifunctional fluorescent probes for viscosity and analytes , 2022, Coordination Chemistry Reviews.
[11] Xiaojing Liu,et al. Dynamic Adjust of Non‐Radiative and Radiative Attenuation of AIE Molecules Reinforces NIR‐II Imaging Mediated Photothermal Therapy and Immunotherapy , 2022, Advanced science.
[12] Xiaobing Zhang,et al. Highly Selective Fluorescent Probe Design for Visualizing Hepatic Hydrogen Sulfide in the Pathological Progression of Nonalcoholic Fatty Liver. , 2021, Analytical chemistry.
[13] Michael E. Dunham,et al. Detection of pancreatic cancer by indocyanine green‐assisted fluorescence imaging in the first and second near‐infrared windows , 2021, Cancer communications.
[14] Kecheng Zhang,et al. Ultrabright and Highly Polarity‐Sensitive NIR‐I/NIR‐II Fluorophores for the Tracking of Lipid Droplets and Staging of Fatty Liver Disease , 2021, Advanced Functional Materials.
[15] Jianjun Du,et al. Molecular Design of Monochromophore-Based Bifunctional Photosensitizers for Simultaneous Ratiometric Oxygen Reporting and Photodynamic Cancer Therapy. , 2021, Analytical chemistry.
[16] N. Wang,et al. Endogenous peroxynitrite activated fluorescent probe for revealing anti‐tuberculosis drug induced hepatotoxicity , 2021, Chinese Chemical Letters.
[17] Yongqing Zhou,et al. Exploring the Changes of Peroxisomal Polarity in the Liver of Mice with Nonalcoholic Fatty Liver Disease. , 2021, Analytical chemistry.
[18] Juyoung Yoon,et al. Rational Design of Highly Selective Near-Infrared Two-Photon Fluorogenic Probe for Imaging Orthotopic Hepatocellular Carcinoma Chemotherapy. , 2021, Angewandte Chemie.
[19] Li-Ya Niu,et al. Visualizing the Underlying Signaling Pathway Related to Nitric Oxide and Glutathione in Cardiovascular Disease Therapy by a Sequentially Activated Fluorescent Probe. , 2021, Analytical chemistry.
[20] Jia Li,et al. Fluorescent probes for the imaging of lipid droplets in live cells , 2021 .
[21] Ji-ting Hou,et al. Fluorescent detectors for hydroxyl radical and their applications in bioimaging: A review , 2020 .
[22] Xiaobing Zhang,et al. A high-selectivity fluorescent reporter toward peroxynitrite in coexisting nonalcoholic fatty liver and drug induced liver diseases model. , 2020, Analytical chemistry.
[23] Juyoung Yoon,et al. An Activatable AIEgen Probe for High-Fidelity Monitoring of Overexpressed Tumor Enzyme Activity and Its Application to Surgical Tumor Excision. , 2020, Angewandte Chemie.
[24] Wei Zhang,et al. Versatile fluorescent probes for visualizing superoxide anion in living cells and in vivo. , 2020, Angewandte Chemie.
[25] Juyoung Yoon,et al. Sensors, Imaging Agents, and Theranostics to Help Understand and Treat Reactive Oxygen Species Related Diseases , 2019, Small Methods.
[26] Peng Yin,et al. SABER enables amplified and multiplexed imaging of RNA and DNA in cells and tissues , 2019, Nature Methods.
[27] Xiaobing Zhang,et al. De Novo Design of Chemical Stability Near-Infrared Molecular Probes for High-Fidelity Hepatotoxicity Evaluation In Vivo. , 2019, Journal of the American Chemical Society.
[28] Hongliang Li,et al. Insights into the Epidemiology, Pathogenesis, and Therapeutics of Nonalcoholic Fatty Liver Diseases , 2018, Advanced science.
[29] Timothy D. Imler,et al. Patients With Chronic Liver Disease Suggestive of Nonalcoholic Fatty Liver Disease May Be at Higher Risk for Drug-Induced Liver Injury. , 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[30] J. Olzmann,et al. Dynamics and functions of lipid droplets , 2018, Nature Reviews Molecular Cell Biology.
[31] I. Wilson,et al. Paracetamol metabolism, hepatotoxicity, biomarkers and therapeutic interventions: a perspective. , 2018, Toxicology research.
[32] A. Wu,et al. A Ultrasensitive Near‐Infrared Fluorescent Probe Reveals Pyroglutamate Aminopeptidase 1 Can Be a New Inflammatory Cytokine , 2018, Advanced science.
[33] Safacan Kolemen,et al. Reaction-based BODIPY probes for selective bio-imaging , 2018 .
[34] C. Hunt,et al. Drug rechallenge following drug‐induced liver injury , 2017, Hepatology.
[35] Jun Yu,et al. Animal models of non‐alcoholic fatty liver disease: current perspectives and recent advances , 2016, The Journal of pathology.
[36] E. Tsochatzis,et al. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). , 2016, Metabolism: clinical and experimental.
[37] B. Vincenzi,et al. Drug-induced hepatotoxicity in cancer patients - implication for treatment , 2016, Expert opinion on drug safety.
[38] Fang Zeng,et al. A two-photon fluorescent sensor revealing drug-induced liver injury via tracking γ-glutamyltranspeptidase (GGT) level in vivo. , 2016, Biomaterials.
[39] I. Bergheim,et al. In Vitro and in Vivo Models of Non-Alcoholic Fatty Liver Disease (NAFLD) , 2013, International journal of molecular sciences.
[40] B. Fromenty. Drug-induced liver injury in obesity. , 2013, Journal of hepatology.
[41] Neil Kaplowitz,et al. Liver biology and pathobiology , 2006, Hepatology.